Is Warren Buffett's $9.7 Billion Acquisition of OxyChem an Act of Brilliance or a Big Mistake for Berkshire Hathaway Investors?

On Jan. 1, 2026, Warren Buffett will step down as chief executive officer (but remain chairman) of Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) -- handing the reins to his successor, Greg Abel. With less than three months before the switchover, Buffett showed he was still in charge by executing a $9.7 billion deal to acquire OxyChem from Occidental Petroleum (NYSE: OXY).Here's what this deal might mean for Berkshire investors and whether it's a mistake or a textbook savvy move by the legendary value investor.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool